March 2, 2026

Alkermes plc (ALKS) Stock Analysis: Exploring a 45% Potential Upside in Biopharma

Alkermes plc (NASDAQ: ALKS) stands as a notable player in the biopharmaceutical sector, focusing on addressing unmet medical needs across a spectrum of therapeutic areas. Based..

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Understanding the 25.56% Upside Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology industry, specializing in RNA-targeted therapeutics and gene therapies aimed at treating rare diseases. With..

BrightSpring Health Services (BTSG) Stock Analysis: A Promising 11.20% Upside Amid Robust Revenue Growth

BrightSpring Health Services, Inc. (BTSG) is capturing the attention of investors with a notable 11.20% potential upside, as indicated by its average target price of $46.07...

Elanco Animal Health (ELAN) Stock Analysis: Navigating a 8.97% Potential Upside in the Booming Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN) is making waves in the healthcare sector, specifically within the realm of specialty and generic drug manufacturing for animals. With..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Research Sector with 10.48% Upside Potential

For investors keen on the healthcare sector, Charles River Laboratories International, Inc. (NYSE: CRL) offers a unique blend of opportunities within the diagnostics and research industry...

Axsome Therapeutics (AXSM): Analyst Consensus Highlights 35% Potential Upside for This Biotech Innovator

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a New York-based biopharmaceutical company, continues to capture investor attention with its focus on developing therapies for central nervous system (CNS)..

TG Therapeutics, Inc. (TGTX) Growth Potential: Navigating a 47.65% Upside in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, is making waves with its promising pipeline and substantial market potential. With a market..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Impressive Growth Potential Amidst Innovative Biotechnology Advances

Roivant Sciences Ltd. (ROIV), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its robust pipeline of clinical-stage biopharmaceuticals. Headquartered..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 1.87% Upside with Robust Revenue Growth

Bausch + Lomb Corporation (NYSE: BLCO), a prominent name in the healthcare sector, is making waves in the medical instruments and supplies industry. With its Canadian..

Option Care Health, Inc. (OPCH) Investor Outlook: Capitalizing on a 23.51% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a leader in the healthcare sector with a focus on medical care facilities, stands out as a formidable player in..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a Pivotal Moment with a 0.28 Forward P/E

Dr. Reddy’s Laboratories Ltd (RDY), a prominent player in the healthcare sector, is a name that resonates with both generic and specialty drug manufacturing. Based in..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 178.79% Potential Upside in Rare Disease Therapeutics

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is gaining attention in the biotechnology sector, with a market capitalization of $2.1 billion and a promising focus on rare disease..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 10.66% Upside Awaits Investors

Investors searching for a promising opportunity in the healthcare sector might find GE HealthCare Technologies Inc. (GEHC) to be a compelling option. With a market capitalization..

Novo Nordisk A/S (NVO) Investor Outlook: Unpacking a 36.51% Potential Upside

Novo Nordisk A/S (NVO), a Denmark-based pharmaceutical giant, is a name that resonates with innovation and leadership in the healthcare sector. Operating primarily in the Obesity..

Henry Schein, Inc. (HSIC): Investor Outlook with a 7.5% Upside Potential

Henry Schein, Inc. (NASDAQ: HSIC) is a stalwart in the healthcare sector, operating within the medical distribution industry. Founded in 1932 and based in Melville, New..

Humana Inc. (HUM) Stock Analysis: Exploring a 17.5% Upside Potential for Investors

Humana Inc. (NYSE: HUM), a powerhouse in the healthcare plans industry, presents an intriguing opportunity for investors, highlighted by a potential upside of 17.5%. As a..

RadNet, Inc. (RDNT) Stock Analysis: Exploring an Attractive 31.43% Upside Potential in the Healthcare Sector

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, has been capturing investor attention with its robust growth potential and strategic positioning within the..

Exact Sciences Corporation (EXAS) Stock Analysis: Evaluating Growth Prospects Amidst Strong Revenue Growth

Exact Sciences Corporation (NASDAQ: EXAS) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Known for its innovative cancer screening..

Tempus AI, Inc. (TEM) Stock Analysis: Strong Revenue Growth and Significant Upside Potential

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector with its innovative offerings and impressive revenue growth. With a market capitalization of..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 59% Potential Upside in the Booming Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is capturing investor attention with its innovative approach to healthcare technology and substantial growth potential. As a leader in the medical..

Search

Funds

March 2, 2026

Search

Funds

March 2, 2026

FTSE 100

Funds